LW
Li Watsek Cantor Fitzgerald Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
26
Avg Return
Past Year
Past Year
4.3%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
100%
Neutral
0%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Financials
Healthcare
Financials
Asset Management
Healthcare
Biotechnology
Drug Manufacturers - General
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Overweight
Maintained
| $254 |
24%
upside
| 7 | +7.9% |
0
%
| 13 Oct ‘25 7 days ago |
|
|
|
Overweight
Initiated
| – | – | 1 | +42% |
0
%
| 2 Oct ‘25 18 days ago |
|
|
|
Overweight
Reiterated
| – | – | 3 | +6.5% |
0
%
| 9 Sep ‘25 1 month ago |
|
|
|
Overweight
Upgraded
| – | – | 2 | +52% |
0
%
| 30 Jul ‘25 2 months ago |
|
|
|
Overweight
Reiterated
| – | – | 5 | -4.6% |
0
%
| 26 Jun ‘25 3 months ago |
|
|
|
Overweight
Reiterated
| – | – | 1 | -16% |
0
%
| 27 Mar ‘25 6 months ago |
|
|
|
Overweight
Reiterated
| – | – | 2 | -36% |
0
%
| 26 Mar ‘25 6 months ago |
|
|
|
Overweight
Initiated
| – | – | 1 | +39% |
0
%
| 14 Mar ‘25 7 months ago |
|
|
|
Overweight
Reiterated
| – | – | 1 | -49% |
0
%
| 7 Feb ‘25 8 months ago |
|
|
|
Overweight
Reiterated
| – | – | 3 | +4% |
0
%
| 24 Jan ‘25 8 months ago |
|
|
|
Overweight
Reiterated
| – | – | 1 | -91% |
0
%
| 19 Nov ‘24 11 months ago |
|